Sustainability Report 2016

Scroll down for 2016 Highlights
Shukra, living with Epilepsy

Creating value for millions of patients

‘Our strategy requires innovation, focus and agility and therefore an evolution to an integrated business model with biotech characteristics, impacting each part of our value chain.’

Jean-Christophe Tellier, CEO

Visit of Jean-Christophe Tellier, CEO, DR Congo
Read letter to stakeholders

Epilepsy care in resource-poor countries

projects-3-new-partnerships.jpg

Uganda, Madagascar and Rwanda

Three new partnerships

In 2016 UCB established three new partnerships for epilepsy care with the Duke University (Uganda), Handicap International (Madagascar) and One Family Health (Rwanda).

More about these projects
projects-brothers-of-charity.jpg

DR Congo and Rwanda

Brothers of Charity

The visit of Jean-Christophe Tellier to the 'Neuropsychiatric center Joseph Guislain' illustrates the important epilepsy disease burden in Lubumbashi (DR Congo).

More about these projects
projects-who.jpg

Mozambique and Myanmar

World Health Organization

Treatment of epilepsy has long been neglected in public health programs notwithstanding its high disease burden, the major impact on people it affects, and access to cost-effective treatment.

More about these projects
projects-china.jpg

China

project HOPE and BDC of Red Cross Society

In China UCB works with two partners
(BDC of Red Cross Society of China and project HOPE) in order to make an impact for patients living with epilepsy.

Also in this Report:

GRI Index

The Sustainability Report is prepared in accordance with the core criteria of the Global Reporting Initiative (GRI) G4 Sustainability Reporting indicators.

View GRI-Index

Downloads Overview

All report downloads in one place:
PDF chapters and XLS tables

View Downloads

Sustainability Data 2016

An overview of our talent, social and environmental data in 2016

View Sustainability Data